Market Analysis

Increasing interest in cholesterol-lowering treatment drives phytosterol sales

Published in Heart Disease Weekly, July 2nd, 2006

With one of the major risk factors for heart disease being elevated cholesterol levels, particularly low-density lipoproteins (LDLs), there is an increasing demand for foods and beverages containing phytosterols or nutraceuticals that lower cholesterol levels.

Frost & Sullivan valued the total European phytosterols market to be worth US$184.6 million in 2005, and estimates this to reach US$395.2 million in 2012.

Today, consumers are actively seeking products containing health-promoting ingredients, such as nutraceuticals, to improve their health and well-being. In keeping with this trend, nutraceuticals such as phytosterols, that have a beneficial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Heart Disease Weekly

Source: Heart Disease Weekly (2006-07-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry